Moreover, Allo15BCAR-NKT cells could kill BCMA−CD1d− tumor cells through NKR (that is, NKG2D and DNAM-1) recognition, confirming an NKR-mediated targeting mechanism (Fig. 2k,l and Supplementary Fig. 7d–f). This evidence concerns the gene CD226 and neoplasm.